170 related articles for article (PubMed ID: 26775918)
1. The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1.
Cabibbo G; Reig M; Gadaleta-Caldarola G; Galati G; Lombardi G; Mazza G; Marzi L; Saitta C; Nault JC; Sacco R
Future Oncol; 2016 Feb; 12(3):281-4. PubMed ID: 26775918
[TBL] [Abstract][Full Text] [Related]
2. The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2.
Cabibbo G; Reig M; Gadaleta-Caldarola G; Galati G; Lombardi G; Mazza G; Marzi L; Saitta C; Nault JC; Sacco R
Future Oncol; 2016 Feb; 12(3):285-8. PubMed ID: 26776157
[TBL] [Abstract][Full Text] [Related]
3. Real practice of hepatocellular carcinoma in Japan: conclusions of the Japan Society of Hepatology 2009 Kobe Congress.
Kudo M
Oncology; 2010 Jul; 78 Suppl 1():180-8. PubMed ID: 20616602
[TBL] [Abstract][Full Text] [Related]
4. Report from European Association for the Study of the Liver: HCC Summit, Geneva, Switzerland, 2-5 February 2017.
Sacco R; Mirabile A; Giacomelli L; Bresci G; Attardo S; Cabibbo G
Future Oncol; 2017 Jun; 13(15):1297-1300. PubMed ID: 28589772
[TBL] [Abstract][Full Text] [Related]
5. Advances in management of hepatocellular carcinoma.
Allaire M; Nault JC
Curr Opin Oncol; 2017 Jul; 29(4):288-295. PubMed ID: 28509806
[TBL] [Abstract][Full Text] [Related]
6. The 9th Annual Conference of the International Liver Cancer Association (ILCA) 2015.
Marquardt JU; Galle PR
Hepat Oncol; 2016 Jan; 3(1):9-12. PubMed ID: 30191023
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the management of hepatocellular carcinoma.
Zhang S; Yue M; Shu R; Cheng H; Hu P
J BUON; 2016; 21(2):307-11. PubMed ID: 27273938
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting.
Burak KW; Sherman M
Can J Gastroenterol Hepatol; 2015 May; 29(4):178-84. PubMed ID: 25965437
[TBL] [Abstract][Full Text] [Related]
9. Advances in Management of Hepatocellular Carcinoma.
Intaraprasong P; Siramolpiwat S; Vilaichone RK
Asian Pac J Cancer Prev; 2016; 17(8):3697-703. PubMed ID: 27644603
[TBL] [Abstract][Full Text] [Related]
10. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.
Omata M; Cheng AL; Kokudo N; Kudo M; Lee JM; Jia J; Tateishi R; Han KH; Chawla YK; Shiina S; Jafri W; Payawal DA; Ohki T; Ogasawara S; Chen PJ; Lesmana CRA; Lesmana LA; Gani RA; Obi S; Dokmeci AK; Sarin SK
Hepatol Int; 2017 Jul; 11(4):317-370. PubMed ID: 28620797
[TBL] [Abstract][Full Text] [Related]
11. Multimodal treatment of hepatocellular carcinoma.
Graf D; Vallböhmer D; Knoefel WT; Kröpil P; Antoch G; Sagir A; Häussinger D
Eur J Intern Med; 2014 Jun; 25(5):430-7. PubMed ID: 24666568
[TBL] [Abstract][Full Text] [Related]
12. Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial.
Vilgrain V; Abdel-Rehim M; Sibert A; Ronot M; Lebtahi R; Castéra L; Chatellier G;
Trials; 2014 Dec; 15():474. PubMed ID: 25472660
[TBL] [Abstract][Full Text] [Related]
13. Management of HCC.
de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
[TBL] [Abstract][Full Text] [Related]
14. Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma.
Carrilho FJ; Mattos AA; Vianey AF; Vezozzo DC; Marinho F; Souto FJ; Cotrim HP; Coelho HS; Silva I; Garcia JH; Kikuchi L; Lofego P; Andraus W; Strauss E; Silva G; Altikes I; Medeiros JE; Bittencourt PL; Parise ER
Arq Gastroenterol; 2015 Dec; 52 Suppl 1():2-14. PubMed ID: 26959803
[TBL] [Abstract][Full Text] [Related]
15. Shaping the future management of hepatocellular carcinoma.
Abou-Alfa G; Colombo M
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S20-3. PubMed ID: 23457036
[TBL] [Abstract][Full Text] [Related]
16. Management of hepatocellular carcinoma: from prevention to molecular targeted therapy. Proceedings of the 3rd International Kobe Liver Symposium on HCC with an International Liver Cancer Association (ILCA) Scientific Session. Hyogo, Japan, June 6-7, 2009.
Oncology; 2010 Jul; 78 Suppl 1():1-190. PubMed ID: 20845532
[No Abstract] [Full Text] [Related]
17. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary management of hepatocellular carcinoma: where are we today?
Marrero JA
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S3-10. PubMed ID: 23457037
[TBL] [Abstract][Full Text] [Related]
19. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
Au JS; Frenette CT
Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma: diagnosis, management, and prognosis.
Page AJ; Cosgrove DC; Philosophe B; Pawlik TM
Surg Oncol Clin N Am; 2014 Apr; 23(2):289-311. PubMed ID: 24560111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
